Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

Fink-Puches, R; Soyer, HP; Hofer, A; Kerl, H; Wolf, P.
Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Arch Dermatol. 1998; 134(7):821-826 Doi: 10.1001%2Farchderm.134.7.821 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

Leading authors Med Uni Graz: Fink-Puches Regina; Wolf Peter
Co-authors Med Uni Graz: Hofer Angelika; Kerl Helmut; Soyer Hans Peter
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: OBJECTIVE: To investigate the immediate and long-term effects of photodynamic therapy with delta-aminolevulinic acid (ALA-PDT) on superficial basal cell carcinomas (BCC) and superficial squamous cell carcinomas (SCC). DESIGN: Retrospective study with 60 months of maximal follow-up. SETTING: University-based hospital in Graz, Austria. PATIENTS: Forty-seven subjects with a total of 95 superficial BCC and 35 superficial SCC. INTERVENTIONS: A compound of 20% delta-aminolevulinic acid was topically applied under an occlusive and light-shielding dressing before exposure to either UV-A or different wave bands of polychromatic visible light (full-spectrum visible light, >515, >570, or >610 nm). MAIN OUTCOME MEASURES: Primary tumor responses and recurrence rates in the long-term follow-up, as well as histological changes associated with ALA-PDT, were studied. RESULTS: The complete primary response rate for all wave bands of light was 86% (82/95) for superficial BCC and 54% (19/35) for superficial SCC. There was no statistically significant difference among the response rates to the different wave bands of light. After a median follow-up of 19 months (range, 3-60 months) for BCC and 8 months (range, 3-47 months) for SCC, the overall recurrence rate was 44% (36/81) and 69% (11/16), respectively. At 36 months after therapy, the projected disease-free rate was 50% (95% confidence interval, 43%-57%) for BCC vs 8% (95% confidence interval, 7%-9%) for SCC (P<.001, log-rank test). Histopathologic studies revealed a significant increase of fibrosis in the dermis after ALA-PDT and appearance of a sharp border between fibrotic and nonfibrotic tissue. In 15 of 16 BCC examined, the border between fibrotic and nonfibrotic tissue was deeper in the dermis than the maximum tumor thickness before therapy (P<.001, Wilcoxon signed rank test). Similar histopathologic observations were made in SCC. CONCLUSIONS: Our study revealed poor long-term cure rates for superficial BCC and SCC treated with topical ALA-PDT and visible light. The histopathologic observations showing remarkable fibrosis in the dermis indicated that the effect of ALA-PDT reached deeper than the initial depth of invasiveness of the neoplastic tissue, suggesting in turn that the poor long-term results of ALA-PDT cannot be explained by insufficient penetration of the therapy effect.
Find related publications in this database (using NLM MeSH Indexing): Administration, Topical -; Aged -; Aged, 80 and over -; Aminolevulinic Acid - administration and dosage; Antineoplastic Agents - administration and dosage; Carcinoma, Basal Cell - drug therapy; Carcinoma, Squamous Cell - drug therapy; Dermatitis, Phototoxic - etiology; Female - etiology; Fluorescence - etiology; Follow-Up Studies - etiology; Humans - etiology; Male - etiology; Melanoma - drug therapy; Middle Aged - drug therapy; Photochemotherapy - adverse effects; Photosensitizing Agents - administration and dosage; Retrospective Studies - administration and dosage; Skin - drug effects; Skin Neoplasms - drug therapy; Time Factors - drug therapy